Other
Cost or Amortized Cost
Medtronic Cost or Amortized Cost increased by 3.0% to $7.26B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.5%, from $6.82B to $7.26B.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2025
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Changes reflect shifts in the size and composition of the fixed-income investment portfolio over time.
Detailed definition
The initial cost of debt securities adjusted for amortization of premiums or accretion of discounts, excluding unrealize...
Peer comparison
Standard accounting metric for insurance companies; peers with larger investment portfolios will show higher amortized costs.
Metric ID:
other_debt_securities_available_for_sale_amortized_cost__050c1eHistorical Data
6 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|
| Value | $6.69B | $6.71B | $6.82B | $6.91B | $7.05B | $7.26B |
| QoQ Change | — | +0.3% | +1.6% | +1.4% | +1.9% | +3.0% |
| YoY Change | — | — | — | +3.3% | +5.0% | +6.5% |
Range$6.69B – $7.26B
CAGR+6.8%
Avg YoY Growth+4.9%
Median YoY Growth+5.0%
Current Streak5+ quarters growth
Cost or Amortized Cost at Other Companies
Frequently Asked Questions
- What is Medtronic's cost or amortized cost?
- Medtronic (MDT) reported cost or amortized cost of $7.26B in Q4 2025.
- How has Medtronic's cost or amortized cost changed year-over-year?
- Medtronic's cost or amortized cost increased by 6.5% year-over-year, from $6.82B to $7.26B.
- What does cost or amortized cost mean?
- The adjusted historical cost of debt securities held for investment purposes.